HUTCHMED (China) (HCM) Share-based Compensation (2020 - 2021)
HUTCHMED (China)'s (HCM) quarterly Share-based Compensation came in at $2.9 million in Q1 2021, up 754.49% year-on-year from $345000.0 in Q1 2020, and up 754.49% on a QoQ basis from $345000.0 in Q1 2020.
HUTCHMED (China) (HCM) Share-based Compensation (2020 - 2021) Analysis & Trends
HUTCHMED (China) (HCM) has 2 years of Share-based Compensation data on file, last reported at $2.9 million in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 43.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 25.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 125.69 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 58.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 56.50 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 55.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.00 Mn |
| 10 | HUTCHMED (China) | 241.90 Mn | 243.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 2.95 Mn |
| Mar 31, 2021 | 2.95 Mn |
| Mar 31, 2020 | 345,000.00 |
| Mar 31, 2020 | 345,000.00 |